Optometrists in Troy, MI Accepting Medicare

67 Optometrists found. Showing 61 - 67

Sandra Shina Hou Od Pc Optometrist Medicare: Medicare Enrolled Practice Location: 2001 W Maple Rd, Wal-mart Vision Center, Troy, MI 48084 Phone: 248-435-4126    Fax: 248-435-4162

Robert John Lloyd, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1200 Kirts Blvd, Suite 200, Troy, MI 48084 Phone: 248-528-1981    Fax: 614-416-2105

Sabiha Fatima Habib, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2800 W Big Beaver Rd, Ste V368, Troy, MI 48084 Phone: 248-816-0990

Dr. Brooke Abbaya, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 735 John R Rd, Troy, MI 48083 Phone: 248-951-0000

Onsight Health Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 100 W Big Beaver Rd, Suite 655, Troy, MI 48084 Phone: 248-528-1981    Fax: 248-528-2183

Steven Gibbs, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 912 E Big Beaver Rd, Troy, MI 48083 Phone: 248-906-8166

Family Optometry Associates, Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2950 E Wattles Rd, Suite 100, Troy, MI 48085 Phone: 248-740-0222    Fax: 248-689-0123

News Archive

Stand Up To Cancer hails FDA approval of new treatment option for aggressive prostate cancer

A recent FDA approval supported by Stand Up To Cancer research provides a new treatment option for patients with an aggressive form of prostate cancer.

Study advances understanding of chronic and progressive nature of gout if treated inadequately

Emeritus professor of medicine, Elisio Pascual, at the Miguel Hernández Univeristy in Elche and former head of the Rheumatology Unit at Alicante University Hospital has published a research paper presenting previously unknown data that contribute to our understanding of gout as a crystal deposition disease.

Asthmatic children receive equal quality of care regardless of race or ethnicity

Asthmatic children admitted to pediatric medical centers received equal quality of care regardless of race or ethnicity, according to a study presented Monday at the 2004 Pediatric Academic Societies meeting in San Francisco, CA.

Global haemophilia therapeutics market estimated to reach $13.43 billion in 2019

Increased uptake of recombinant therapies and prophylactic use, coupled with improved diagnosis of haemophilia, is expected to drive the associated therapeutics market. Recombinant therapies are likely to command a premium price and fuel growth in developed markets, while heightened access to treatment and larger patient volumes due to more funding for critical care are anticipated to contribute to demand in emerging markets.

Appropriate timing in the use of breast shields in children can further reduce MDCT radiation dose

Using breast shields during pediatric chest MDCT reduces radiation dose and minimally increases image noise, according to a recent study conducted by researchers at Duke University Medical Center in Durham, NC and the University of Arkansas for Medical Sciences and Arkansas Children's Hospital in Little Rock.

Read more Medical News

› Verified 7 days ago

• 1
• 2
• 3
• 4(current)